Stay updated on Pembrolizumab + Paclitaxel in HR+ MBC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Paclitaxel in HR+ MBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Paclitaxel in HR+ MBC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page footer revision label was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a minor technical/version change without affecting the posted study details.
    Difference
    0.1%
    Check dated 2026-04-26T08:22:01.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-19T01:35:58.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    42 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.3 to v3.5.0; no substantive content changes are evident.
    Difference
    0.1%
    Check dated 2026-03-21T08:37:59.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-06T19:28:26.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    The page revision label updated from v3.4.1 to v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-13T13:18:54.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    A minor revision update was applied: v3.4.1 was added and v3.4.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-05T23:54:11.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Paclitaxel in HR+ MBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Paclitaxel in HR+ MBC Clinical Trial page.